Effect of Preoperative Oral Energy Drinks Compared to Warming Matress on Body Temperature During Combined Spinal-epidural Anesthesia for Elective Cesarean Delivery.

August 29, 2023 updated by: Yi Feng, MD, Peking University People's Hospital

Effect of Preoperative Oral Energy Drinks Compared to Warming Matress on Body Temperature During Combined Spinal-epidural Anesthesia for Elective Cesarean Delivery: a Randomised Non-inferiority Trial.

It is not known which is better for intraoperative temperature protection, warming matress or preoperative oral functional drinks in elective cesarean section. We plan to conduct a non inferiority randomized trial to clarify this problem.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

280

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Women pregnant with a single fetus;
  • American Society of Anesthesiologists (ASA) physical status II;
  • Willingness to undergo elective cesarean delivery under CSEA;
  • An age of 20-40 years;
  • A body mass index (BMI) of 19-30 kg·m-2;
  • A gestational age of 38-40 weeks.

Exclusion Criteria:

  • Contraindications for CSEA;
  • A diagnosis of delayed gastric emptying, hyperemesis gravidarum until late pregnancy, or consumption of drugs that affect gastrointestinal motility within 3 days before surgery;
  • Preoperative body temperature >38°C or <36°C or the use of drugs that affect body temperature;
  • Pregnancy combined with diabetes, hypertension, or metabolic disorders (eg, hypothyroidism or hyperthyroidism);
  • Ear diseases (eg, otitis media, tympanic membrane perforation, etc) affecting measurement of ear temperature .
  • Patients who were simultaneously undergoing other operations (eg, removal of uterine fibroids and ovarian cysts) or had a surgical time >1.5 hours;
  • Patients with blood transfusion or autologous blood transfusion intraoperatively;
  • Patients who did not receive the anesthetic specified in the protocol;
  • Patients who failed to drink adequate energy drinks as prescribed before surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: warming matress group
From the end of anesthesia, warming matriss at 40 ℃ was used for insulation until the end of surgery.
From the end of anesthesia, warming matriss at 40 ℃ was used to keep warm until the end of surgery.
Experimental: oral functional drinks group
Patients drank energy drinks (Red Bull®) 250ml about 2-2.5 hours before operation.
Patients drank energy drinks (Red Bull®) 250ml about 2-2.5 hours before operation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Core temperature change
Time Frame: Before the operation, and every 10 minutes during the operation until the end of the operation.
The minimum value of intraoperative ear temperature minus the preoperative baseline ear temperature.
Before the operation, and every 10 minutes during the operation until the end of the operation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of nausea in pregnant women
Time Frame: Intraoperative
Anesthesiologist observes combined patient dictation.
Intraoperative
The incidence of vomiting in pregnant women
Time Frame: Intraoperative
Anesthesiologist observes combined patient dictation
Intraoperative
hypotension
Time Frame: Intraoperative
Number of Participants with systolic blood pressure reduction >20% baseline value or systolic blood pressure <90 mm Hg before delivery
Intraoperative
Umbilical artery blood base excess
Time Frame: 30sec after delivery
base excess of fetal umbilical artery blood
30sec after delivery
Skin temperature changes
Time Frame: Before the operation, and every 10 minutes during the operation until the end of the operation.
The minimum value of intraoperative skin temperature minus the preoperative baseline skin temperature.
Before the operation, and every 10 minutes during the operation until the end of the operation.
The incidence of shivering in pregnant women
Time Frame: Intraoperative
Anesthesiologist observes combined patient dictation
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

August 24, 2023

First Submitted That Met QC Criteria

August 29, 2023

First Posted (Actual)

August 30, 2023

Study Record Updates

Last Update Posted (Actual)

August 30, 2023

Last Update Submitted That Met QC Criteria

August 29, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • SFY2023-MZ8-3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section Complications

Clinical Trials on Warming matress

3
Subscribe